Trial Details
COMPLETEDBasic Information
| Clinical ID | c3370 |
|---|---|
| Identifier | NCT02155335 |
| Trial Title | Preference for a Prefilled Syringe or Smartject™ Device for Delivering Golimumab in Participants Suffering From Moderate-to-severe Ulcerative Colitis (MK-8259-027) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Prefilled Syringe delivery of Golimumab|DRUG: Smartject Device delivery of Golimumab |
Participant Information
| Sponsor | Merck Sharp & Dohme LLC |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2014-07-01 |
|---|---|
| Primary Completion Date | 2015-10-05 |
| Completion Date | 2015-10-05 |